Skip to Content

Zyclara Approval History

FDA Approved: Yes (First approved March 25, 2010)
Brand name: Zyclara
Generic name: imiquimod
Dosage form: Cream
Company: Graceway Pharmaceuticals, LLC
Treatment for: Keratosis, Condylomata Acuminata

Zyclara (imiquimod) is an immune response modifier indicated for the topical treatment of actinic keratoses and external genital warts.

Development History and FDA Approval Process for Zyclara

DateArticle
Jul 29, 2011Approval FDA Approves Zyclara (imiquimod) Cream, 2.5% for the Treatment of Actinic Keratoses
Mar 25, 2011Approval FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts
Mar 29, 2010Approval FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of Actinic Keratoses

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide